Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ultrio Assay to the Grifols Procleix Ultrio Elite Assay on the fully automated Panther System.
Read all about it on the Communication page by clicking the this link:Communications
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...